120 related articles for article (PubMed ID: 7477781)
21. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
22. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats.
Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D
Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303
[TBL] [Abstract][Full Text] [Related]
23. Treatment of experimental brain tumors with trombospondin-1 derived peptides: an in vivo imaging study.
Bogdanov A; Marecos E; Cheng HC; Chandrasekaran L; Krutzsch HC; Roberts DD; Weissleder R
Neoplasia; 1999 Nov; 1(5):438-45. PubMed ID: 10933059
[TBL] [Abstract][Full Text] [Related]
24. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
[TBL] [Abstract][Full Text] [Related]
25. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats.
DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A
J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528
[TBL] [Abstract][Full Text] [Related]
26. The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma.
Olson JJ; Polk DM; Reisner A
Neurosurgery; 1994 Feb; 34(2):297-308; discussion 308. PubMed ID: 8177391
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone inhibits glioma-induced formation of capillary like structures in vitro and angiogenesis in vivo.
Wolff JE; Mölenkamp G; Hotfilder M; Laterra J
Klin Padiatr; 1997; 209(4):275-7. PubMed ID: 9293462
[TBL] [Abstract][Full Text] [Related]
28. Functional magnetic resonance (fMR) imaging of a rat brain tumor model: implications for evaluation of tumor microvasculature and therapeutic response.
Mazurchuk R; Zhou R; Straubinger RM; Chau RI; Grossman Z
Magn Reson Imaging; 1999 May; 17(4):537-48. PubMed ID: 10231180
[TBL] [Abstract][Full Text] [Related]
29. Microglia phagocytose alloreactive CTL-damaged 9L gliosarcoma cells.
Kulprathipanja NV; Kruse CA
J Neuroimmunol; 2004 Aug; 153(1-2):76-82. PubMed ID: 15265665
[TBL] [Abstract][Full Text] [Related]
30. The role of minocycline in the treatment of intracranial 9L glioma.
Weingart JD; Sipos EP; Brem H
J Neurosurg; 1995 Apr; 82(4):635-40. PubMed ID: 7897527
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency electromagnetic fields have no effect on the in vivo proliferation of the 9L brain tumor.
Higashikubo R; Culbreth VO; Spitz DR; LaRegina MC; Pickard WF; Straube WL; Moros EG; Roti JL
Radiat Res; 1999 Dec; 152(6):665-71. PubMed ID: 10581537
[TBL] [Abstract][Full Text] [Related]
32. MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis.
Pathak AP; Schmainda KM; Ward BD; Linderman JR; Rebro KJ; Greene AS
Magn Reson Med; 2001 Oct; 46(4):735-47. PubMed ID: 11590650
[TBL] [Abstract][Full Text] [Related]
33. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
[TBL] [Abstract][Full Text] [Related]
34. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor.
Zhang Z; Jiang Q; Jiang F; Ding G; Zhang R; Wang L; Zhang L; Robin AM; Katakowski M; Chopp M
Neuroimage; 2004 Sep; 23(1):281-7. PubMed ID: 15325375
[TBL] [Abstract][Full Text] [Related]
35. A new technique for implanting intracranial 9L tumors in rats.
Wilkins DE; Raaphorst GP; Saunders JK; Smith IC
Lab Anim Sci; 1993 Oct; 43(5):518-9. PubMed ID: 8277742
[No Abstract] [Full Text] [Related]
36. Boron neutron capture therapy of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.
Morris GM; Coderre JA; Micca PL; Lombardo DT; Hopewell JW
Br J Radiol; 2000 Apr; 73(868):429-34. PubMed ID: 10844870
[TBL] [Abstract][Full Text] [Related]
37. Suppression of tumor growth in experimental 9L gliosarcoma model by copper depletion.
Philipov P
Neurol Med Chir (Tokyo); 1996 Feb; 36(2):115-6. PubMed ID: 8907016
[No Abstract] [Full Text] [Related]
38. Evaluation of lipid-coated microbubbles as a delivery vehicle for Taxol in brain tumor therapy.
Ho SY; Barbarese E; D'Arrigo JS; Smith-Slatas C; Simon RH
Neurosurgery; 1997 Jun; 40(6):1260-6; discussion 1266-8. PubMed ID: 9179900
[TBL] [Abstract][Full Text] [Related]
39. Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.
Quarles CC; Krouwer HG; Rand SD; Schmainda KM
Technol Cancer Res Treat; 2005 Jun; 4(3):245-9. PubMed ID: 15896079
[TBL] [Abstract][Full Text] [Related]
40. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.
Lewis JS; Sharp TL; Laforest R; Fujibayashi Y; Welch MJ
J Nucl Med; 2001 Apr; 42(4):655-61. PubMed ID: 11337556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
